MedTrace Logo

Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)

NCT00204620 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2007-04-20

No results posted yet for this study

Summary

The aims of this trial are to evaluate the efficacy of bendamustin in patients with metastatic soft tissue sarcoma who have progressed after or during an anthracycline-baesd chemotherapy and to assess the treatment of toxicity.

Conditions

  • Sarcoma, Soft Tissue

Interventions

DRUG

Bendamustin

Sponsors & Collaborators

  • Arbeitsgemeinschaft fur Internistische Onkologie

    collaborator OTHER

  • German Sarcoma Group

    collaborator OTHER

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Joerg T Hartmann, MD · South West German Cancer Center, Medical Center II, University of Tuebingen

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-31
Completion
2006-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00204620 on ClinicalTrials.gov